Literature DB >> 8614527

Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents.

J Tateishi1, T Kitamoto, M Z Hoque, H Furukawa.   

Abstract

Sporadic Creutzfeldt-Jakob disease (CJD) with 129M/M, and iatrogenic and familial CJD with E200K and M232R, showed similar clinicopathologic features, a synaptic type deposition of PrPCJD, and high transmission frequencies to mice. Sporadic patients with 129M/V or 129V/V, and mutation cases with V180I, showed slightly different features and low or null transmission frequencies to mice. Hereditary cases with P102L, P105L, A117V, Y145stop, and insertions had different features but all demonstrated a long clinical duration and the presence of PrP plaques. The experimental transmission to mice of these mutant forms was difficult, except for one-third of the cases with P102L. CJD and related diseases, even those that are hereditary, may thus be divided into two different groups, those that are easily transmissible and those that are either difficult to transmit or nontransmissible.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8614527     DOI: 10.1212/wnl.46.2.532

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  47 in total

1.  Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation.

Authors:  Bishwajit Kundu; Nilesh R Maiti; Eric M Jones; Krystyna A Surewicz; David L Vanik; Witold K Surewicz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

Review 2.  Prions.

Authors:  David W Colby; Stanley B Prusiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

3.  Protection from cytosolic prion protein toxicity by modulation of protein translocation.

Authors:  Neena S Rane; Jesse L Yonkovich; Ramanujan S Hegde
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

4.  Transmissible spongiform encephalopathies and tissue cell culture.

Authors:  D N Galbraith
Journal:  Cytotechnology       Date:  2002-07       Impact factor: 2.058

5.  Correlation analysis for the incubation period of prion disease.

Authors:  Se-Eun Bae; Sunghoon Jung; Ha-Yeon Kim; Hyeon S Son
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

Review 6.  (Ctm)PrP and ER stress: a neurotoxic mechanism of some special PrP mutants.

Authors:  Qi Shi; Xiao-Ping Dong
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

Review 7.  PrP assemblies: spotting the responsible regions in prion propagation.

Authors:  Stéphanie Prigent; Human Rezaei
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

Review 8.  Prion protein biosynthesis and its emerging role in neurodegeneration.

Authors:  Oishee Chakrabarti; Aarthi Ashok; Ramanujan S Hegde
Journal:  Trends Biochem Sci       Date:  2009-05-15       Impact factor: 13.807

9.  Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Authors:  Emmanuel A Asante; Ian Gowland; Andrew Grimshaw; Jacqueline M Linehan; Michelle Smidak; Richard Houghton; Olufunmilayo Osiguwa; Andrew Tomlinson; Susan Joiner; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

10.  Immunopurification of pathological prion protein aggregates.

Authors:  Emiliano Biasini; Laura Tapella; Susanna Mantovani; Matteo Stravalaci; Marco Gobbi; David A Harris; Roberto Chiesa
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.